Ken Ohmine
Shimotsuke, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 101 publications
MRD-guided induction-intensification with daratumumab-carfilzomib-based regimen followed by ASCT in patients with newly diagnosed multiple myeloma.
Journal: Leukemia & lymphoma
Published: September 06, 2026
Pneumocystis jirovecii infection in autologous hematopoietic stem cell transplantation.
Journal: Leukemia & lymphoma
Published: January 23, 2026
Soluble PD-L1-secreting umbilical cord-derived mesenchymal stromal cells transiently attenuate established xenogeneic T cell activation in vivo.
Journal: Scientific reports
Published: January 06, 2026
Complement activation profile in adult primary immune thrombocytopenia.
Journal: Blood
Published: December 05, 2025
Cost-effectiveness of blinatumomab as post-remission therapy in adults with measurable residual disease-negative, Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia.
Journal: British journal of haematology
Published: October 14, 2025
Trichostatin A Sensitizes Tumor Cells to Apoptosis Induced by Soluble Trimeric TRAIL-Expressing Human Mesenchymal Stromal Cells.
Journal: Cancer science
Published: September 02, 2025
Threshold for cytomegalovirus DNA PCR for preemptive treatment after allogeneic stem cell transplantation.
Journal: International journal of hematology
Published: August 27, 2025
Significance of the tendency for relative bradycardia during induction therapy for acute myeloid leukemia.
Journal: International journal of hematology
Published: July 02, 2025
Risk factors for influenza virus infection in patients with hematological disease.
Journal: Leukemia & lymphoma
Published: April 24, 2025
Last Updated: 09/26/2026